HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01659

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 190 to 209 of 555 < previous next >

Title	Author(s)	Issue Date
HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Sonneveld, MJ Chiu, S-M Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Zu Siederdissen, CN Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B CREATE study group,	2021
HBsAg loss is higher among caucasians compared to Asians after stopping nucleos(t)ide analogue therapy: results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study) Proceeding/Conference:Hepatology	Hirode, G Choi, HSJ Su, TH Wong, GLH Seto, WKW Hees, SV Papatheodoridi, M Brakenhoff, S Lens, S Sarowar, A Chien, RN Forns, X Sonneveld, MJ Papatheodoridis, G Vanwolleghem, T Yuen, RMF Chan, HLY Kao, JH Hsu, YC Chen, CH Hansen, BE Cornberg, M Jeng, WJ Janssen, HLA RETRACT-B Study Group,	2020
HBV and immunosuppression: appropriate risk stratification Proceeding/Conference:International Symposium on Hepatology - Annual Scientific Meeting of the Hong Kong Association for the Study of Liver Disease, HKASLD 2015	Seto, WKW	2015
HBV and Immunosuppression: What is the risk? Proceeding/Conference:Symposium: State Key Laboratory for Liver Research, The University of Hong Kong	Seto, WKW	2017
HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY Journal:Gastroenterology	Sonneveld, MJ Chiu, S-M Park, JY Brakenhoff, SM Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M Colombatto, P Van Bömmel, F Janssen, HL Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Brunetto, M Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, C-H Maasoumy, B	26-Sep-2023
HBV DNA levels predict significant liver histology for HBeAg-negative chronic hepatitis B patients Proceeding/Conference:Gastroenterology	Seto, WKW Lai, CL Fung, JYY Yuen, JCH Wong, DKH Yuen, RMF	2010
HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB Journal:Clinical and Molecular Hepatology	Mak, LY Wong, DKH Kuchta, A Hilfiker, M Hamilton, A CHOW, N MAO, X Seto, WKW Yuen, RMF	2022
HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma Proceeding/Conference:Hepatology	Wong, D Huang, FY Poon, RT Lai, CL Fung, J Seto, WK Hung, IFN Yuen, MF	2010
HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti-viral therapy Journal:Hepatology	Mak, LY Cloherty, G Wong, DKH Gersch, J Seto, WK Fung, J Yuen, MF	2020
HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA Journal:Scientific Reports	CHONG, CK Cheng, CYS Tsoi, SYJ Huang, F-Y LIU, F Fung, J Seto, W-K Lai, KK-Y Lai, C-L Yuen, R-M Wong, DK-H	2020
HBx蛋白及其羧基末端缺失35个氨基酸的突变体对正常肝细胞增殖的影响 Journal:世界华人消化杂志 = World Chinese Journal of Digestology	Zhu, RX Yang, D Seto, WKW	2018
HCV Direct-acting Antivirals: Real World Data Proceeding/Conference:Scientific Symposium on Transforming HCV care with ONE solution: Real world data from bench to bedside	Seto, WKW	2016
HCV Infection: Towards Eradication Proceeding/Conference:Asia-Pacific Congress of Clinical Microbiology and Infection	Seto, WKW	2018
Hepatic decompensation and hepatocellular carcinoma after stopping nucleos (t)ide analogue therapy: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study) Proceeding/Conference:Journal of Hepatology	Hirode, G Hansen, B Chen, CH Su, TH Wong, GLH Seto, WKW Hees, SV Papatheodoridi, M Brakenhoff, S Lens, X Choi, HSJ Chien, RN Feld, J Forns, X Sonneveld, M Papatheodoridis, G Vanwolleghem, T Yuen, RMF Chan, H Kao, JH Hsu, YC Cornberg, M Jeng, RWJ Jassen, H	2021
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study Journal:Journal of Viral Hepatitis	Leow, YW Chan, WK Goh, GB Wong, VW Fan, JG Kim, YS Kim, SU Nakajima, A Seto, WKW Lee, IC Huang, YH Kim, YJ Jang, JY Chow, WC	2023
Hepatic steatosis via controlled attenuation parameter measurements and diabetes contribute to persistent liver fibrosis in the era of long-term nucleoside analogue therapy for chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Seto, WKW Hui, R Mak, LYL Liu, SHK Cheung, KSM Fung, JYY Wong, DKH Lai, CL Yuen, RMF	2017
Hepatitis B core protein as a therapeutic target Journal:Expert Opinion On Therapeutic Targets	Mak, LY Wong, DKH Seto, WKW Lai, CL Yuen, RMF	2017
Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma Journal:Journal of Viral Hepatitis	To, WP Mak, LY Wong, DKH Fung, J Liu, F Seto, WK Lai, CL Yuen, MF	2019
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study Journal:Hepatology	Seto, WKW Chan, SYT Hwang, YYG Wong, DKH Fung, JYY Liu, SHK Singh, GHH Lam, YF Lau, EHY Cheung, KSM Lie, AKW Lai, CL Kwong, YL Yuen, RMF	2017
Hepatitis B reactivation in patients with previous Hepatitis B Virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study Journal:Journal of Clinical Oncology	Seto, WK Chan, TSY Hwang, YY Wong, DKH Fung, J Liu, KSH Singh, G Lam, YF Lie, AKW Lai, CL Kwong, YL Yuen, MF	2014

Showing results 190 to 209 of 555 < previous next >